Drugs / RO5027838
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00823680 | Apr → Aug 2009 | type 2 diabetes mellitus | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RO5027838 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00823680 ↗ |
| Modality | Small molecule | — CHEMBL6068559 ↗ |
| Route | Oral | “200mg po qd for 4 weeks” NCT00823680 ↗ |